Sengupta, Kasturi
Loro, Emanuele
Khurana, Tejvir S.
Funding for this research was provided by:
Muscular Dystrophy Association
Article History
Received: 26 March 2020
Accepted: 21 October 2020
First Online: 9 December 2020
Competing interests
: TSK is co-inventor on the patent “Methods for enhancing utrophin production via inhibition of microRNA” WO US WO2009134710A3, and other patents and filings related to utrophin upregulation and DMD therapies. The intellectual property is owned and managed by the CTT, University of Pennsylvania. The rest of authors have no conflict of interest.